About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 184 record(s)
Req # A-2023-00032
Job descriptions for all staff in the Data Science Division at Statistics Canada. The job descriptions should indicate classification of the employees. The job descriptions should include the following titles, as well as any others not listed. - Director (Data Science Division) - Assistant Director - Analyst - Senior Advisor - Chief - Chief, Development and Management - Unit Head - Enterprise Portfolio Manager - Unit Head, Senior Analyst - Data Scientist - Unit Head, Senior Economist - Senior Economist - Senior Analyst - Lead Data Scientist - Portfolio & Outreach Analyst - Account Executive - Senior Data Scientist - Student, Co-operative Program - Methodologist - Support technician - Coordinator - FSWEP studentOrganization: Statistics Canada
June 2023
Req # A-2022-00403
Provide copies of documents showing all costs associated with the planning and launch of the most recent cycle of the Canadian Health Measures SurveyOrganization: Statistics Canada
May 2023
Req # A-2022-05126
Provide all emails with keyword “ATIP” from May 1, 2021 to February 23, 2022.Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2021-24940
Provide all emails sent to/from Tanya Potashnik from May 1, 2021, to December 19, 2021. Exclude media scans.Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2023-09059
Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th, 2022. This request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well. This part of the request also runs from October 6th to December 7th, 2022.Organization: Patented Medicine Prices Review Board Canada
March 2023
Req # A-2023-03268
Part 1: Based on documents disclosed in A-2022-09063, (see PDF pages 67-68), the PMPRB sent a letter to the Minister of Health on or around November 30, 2022. I would like to request a copy of that letter, as well as any response from Health Canada. Part 2: Based on documents disclosed in A-2022-09063, a meeting of the PMPRB occurred on December 5th, 2022 (see PDF page 19 of A-2022-09063). I would like to request the following records related to that meeting: 1. A list of attendees for the meeting. 2. A copy of the calendar invitation for the meeting (regardless of program: Outlook, Google meetup, etc), including any attachments to the invite. 3. The agenda for the meeting. 4. The minutes of the meeting. 5. Any notes taken by participants in the meeting. 6. Any documents distributed or discussed during the meeting (such as handouts or powerpoints). 7. Any emails sent by the participants in the meeting which summarized the meeting or discussed next steps.Organization: Patented Medicine Prices Review Board Canada
March 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09228
All correspondence between PMPRB Board members and PMPRB staff pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson, Mélanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09229
All correspondence between the former PMPRB Acting Chairperson, Melanie Bourassa-Forcier, and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023